Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0052 | 1 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0022 | 0.1694 | 0.1694 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1894 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0041 | 0.7093 | 0.6922 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.6359 | 0.6145 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0022 | 0.1894 | 0.1415 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 0.3464 | 0.3078 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0039 | 0.6359 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 0.3452 | 0.3066 |
Echinococcus granulosus | dna polymerase kappa | 0.0022 | 0.1894 | 0.1415 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0052 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase tor, putative | 0.0025 | 0.2511 | 0.2511 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0041 | 0.7093 | 0.6922 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0044 | 0.7923 | 0.78 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0022 | 0.1894 | 0.5 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0022 | 0.1894 | 0.1415 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0031 | 0.4198 | 0.3855 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0022 | 0.1894 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0031 | 0.4282 | 0.3945 |
Giardia lamblia | GTOR | 0.0052 | 1 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1415 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0031 | 0.4282 | 0.3945 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0036 | 0.5739 | 0.5488 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1894 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0052 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.6359 | 0.6145 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0041 | 0.7105 | 0.7105 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 0.3452 | 0.3066 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.6359 | 0.6145 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 0.3452 | 0.3066 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0022 | 0.1894 | 0.1415 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0034 | 0.5016 | 0.4722 |
Echinococcus granulosus | dna polymerase eta | 0.0052 | 0.9947 | 0.9944 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1894 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1415 |
Leishmania major | target of rapamycin (TOR) kinase 1, putative | 0.0052 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.6359 | 0.6145 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 0.3464 | 0.3078 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0041 | 0.7093 | 0.6922 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1894 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0052 | 1 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0052 | 0.9947 | 0.9944 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0035 | 0.5323 | 0.5047 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1894 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0041 | 0.7093 | 0.6922 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1415 |
Leishmania major | DNA polymerase eta, putative | 0.0036 | 0.5739 | 0.5488 |
Echinococcus multilocularis | dna polymerase eta | 0.0052 | 0.9947 | 0.9944 |
Trypanosoma brucei | unspecified product | 0.0022 | 0.1894 | 0.1894 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0022 | 0.1894 | 0.1415 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1894 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0041 | 0.7105 | 0.6934 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0052 | 0.9947 | 0.9947 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0052 | 0.9947 | 0.9944 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0052 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1894 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1415 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.6359 | 0.6145 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0031 | 0.4198 | 0.3855 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0052 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.6359 | 0.6145 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0052 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.9947 | 0.9944 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0022 | 0.1894 | 0.1894 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0052 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1894 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0022 | 0.1894 | 0.1415 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0022 | 0.1894 | 0.1415 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0022 | 0.1894 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1894 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0017 | 0.0557 | 0.0557 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0022 | 0.1894 | 0.1894 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0052 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0041 | 0.7093 | 0.6922 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0052 | 1 | 1 |
Leishmania major | target of rapamycin (TOR) kinase 2, putative | 0.0052 | 1 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0052 | 0.9947 | 0.9944 |
Schistosoma mansoni | DNA polymerase eta | 0.0052 | 0.9947 | 0.9944 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0052 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 0.3464 | 0.3078 |
Echinococcus multilocularis | dna polymerase kappa | 0.0022 | 0.1894 | 0.1415 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0017 | 0.0557 | 0.0557 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0052 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0039 | 0.6359 | 0.6145 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0022 | 0.1894 | 0.1415 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0022 | 0.1894 | 0.1415 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1894 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0022 | 0.1894 | 0.1894 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0028 | 0.3464 | 0.3078 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0052 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0031 | 0.4282 | 0.3945 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0022 | 0.1894 | 0.5 |
Leishmania major | target of rapamycin kinase (TOR) kinase 3 | 0.0041 | 0.7105 | 0.6934 |
Leishmania major | DNA polymerase kappa, putative | 0.0022 | 0.1894 | 0.1415 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0022 | 0.1894 | 0.1415 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.